10-Q/A: Quarterly report pursuant to Section 13 or 15(d)
Published on December 4, 1998
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
AMENDMENT NO. 1
/X/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1998
Commission File Number 0-9314
ACCESS PHARMACEUTICALS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 83-0221517
- ------------------------ --------------------------
(State of Incorporation) (I.R.S. Employer I.D. No.)
2600 Stemmons Frwy, Suite 176, Dallas, TX 75207
-----------------------------------------------
(Address of principal executive offices)
Telephone Number (214) 905-5100
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports) and (2) has been subject to such filing
requirement for the past 90 days.
Yes X No
----- -----
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Common stock outstanding as
of August 14, 1998 3,426,695 shares, $0.01 par value
--------------- ---------
PART II -- OTHER INFORMATION
ITEM 6 EXHIBITS AND REPORTS ON FORM 8-K
Exhibits: 3.8 Certificate of Amendment of Certificate of
Incorporation filed June 18, 1998
(previously filed)
10.13 Agreement between Access Pharmaceuticals, Inc. and
Block Drug Company, Inc.
(Confidential Treatment Requested)
10.14 Sales Agency Agreement (previously filed)
10.15 Registration Rights Agreement (previously filed)
27.1 Financial Data Schedule (previously filed)
Reports on Form 8-K: None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Amendment No. 1 to be signed on its behalf
by the undersigned, thereunto duly authorized.
ACCESS PHARMACEUTICALS, INC.
Date: December 4, 1998 By: /s/ Kerry P. Gray
----------------- ------------------
Kerry P. Gray
President and Chief Executive Officer
(Principal Executive Officer)
Date: December 4, 1998 By: /s/ Stephen B. Thompson
----------------- ------------------------
Stephen B. Thompson
Chief Financial Officer
(Principal Financial and Accounting Officer)